MLAB
Mesa Laboratories, Inc.
Technology · Scientific & Technical Instruments · NMS
$108.46
Close 2026-05-22
✓ ETHICAL PASS
WEAK MOAT
HIGH
Data Confidence: 100%
Full financial profile available
Market Cap
$599.2M
Trailing P/E
164.33
Forward P/E
20.12
Rev Growth
+3.6%
Profit Margin
1.5%
ROE
2.2%
Analyst Target
$104.50
Recommendation
NONE
Ethical Screen
| Business Activity | PASS |
| Debt Ratio (0.28%) | PASS |
| Cash Ratio (0.05%) | PASS |
| Receivables Ratio (0.00%) | PASS |
| Revenue Ratio (0.00%) | PASS |
| Overall | PASS |
Score Valuation: 44.5
Score Quality: 38.2
Score Combined: 41.2
Fair Value Est: $80.85 · Margin of Safety: -25.5%
Opportunity Scores
Valuation69.7
Quality13.4
Cash Flow50.0
Moat25.0
Balance Sheet69.1
Debt Purity14.0
Liquid Purity84.6
Rev Purity100.0
Compliance60.1
Tier: BRONZE · Score: 40.8 · Rank: #4152
Earnings History (Last 8 Quarters)
| Date | EPS Est. | Reported EPS | Surprise % |
|---|---|---|---|
| 2026-05-27 | 1.39 | Pending | -- |
| 2026-02-03 | 1.47 | 1.76 | +19.9% |
| 2025-11-06 | 1.56 | 2.11 | +35.1% |
| 2025-08-05 | 0.44 | 0.85 | +94.7% |
| 2025-05-28 | 2.07 | 0.43 | -79.4% |
| 2025-02-04 | 1.51 | 0.79 | -47.6% |
| 2024-11-07 | 1.38 | 2.16 | +56.5% |
| 2024-08-05 | 1.55 | 1.96 | +26.2% |
Quarterly Financials
| Period | Revenue | Net Income | EBITDA | Gross Profit | Op. Income | EPS |
|---|---|---|---|---|---|---|
| 2025-12-31 | $65.1M | $3.6M | $13.3M | $41.8M | $8.0M | 0.66 |
| 2025-09-30 | $60.7M | $2.5M | $10.7M | $37.3M | $4.7M | 0.45 |
| 2025-06-30 | $59.5M | $4.7M | $15.2M | $36.9M | $3.1M | 0.87 |
| 2025-03-31 | $62.1M | -$7.1M | $10.5M | $38.4M | $1.5M | -1.31 |
| 2024-12-31 | $62.8M | -$1.7M | $6.1M | $39.8M | $5.8M | -0.31 |
Insider Transactions
| Date | Name | Role | Shares | Value |
|---|---|---|---|---|
| 2026-03-10 | TRIPENY R TONY | Director | 1,315 | $99.9K |
| 2026-03-10 | CAPONE MARK CHRISTOPHER | Director | 1,301 | $99.3K |
| 2026-03-10 | LADIWALA SHIRAZ SHABANALI | Director | 3,500 | $252.8K |
| 2025-12-02 | SULLIVAN JOHN JAMES | Director | 2,000 | -- |
| 2025-10-27 | OWENS GARY M | Chief Executive Officer | 11,558 | -- |
| 2025-08-15 | HALL SHANNON | Director | 1,404 | -- |
| 2025-08-15 | LADIWALA SHIRAZ SHABANALI | Director | 1,949 | -- |
| 2025-08-15 | ALLTOFT JENNIFER SADIE | Director | 1,404 | -- |
| 2025-08-15 | SULLIVAN JOHN JAMES | Director | 1,404 | -- |
| 2025-08-15 | TRIPENY R TONY | Director | 1,404 | -- |
Top Institutional Holders
| Holder | Shares | Value | % Held |
|---|---|---|---|
| Long Path Partners LP | 405.6K | $44.1M | 0.1% |
| Blackrock Inc. | 393.9K | $42.8M | 0.1% |
| Boston Partners | 268.7K | $29.2M | 0.0% |
| Select Equity Group LP | 235.9K | $25.6M | 0.0% |
| Vanguard Capital Management LLC | 232.6K | $25.3M | 0.0% |
| Ranger Investment Management, L.p. | 202.9K | $22.0M | 0.0% |
| AQR Capital Management, LLC | 170.6K | $18.5M | 0.0% |
| Morgan Stanley | 162.1K | $17.6M | 0.0% |
| Royce & Associates LP | 161.2K | $17.5M | 0.0% |
| Diamond Hill Capital Management Inc | 155.3K | $16.9M | 0.0% |
Analyst Recommendations
Last Month
3 analysts
Current
3 analysts
Strong Buy
Buy
Hold
Sell
Strong Sell
Additional Fundamentals
Enterprise Value
$739.8M
$739.8M
Price/Book
3.22
3.22
Beta
0.940
0.940
Analysts
2
2
Total Revenue (TTM)
$247.5M
$247.5M
Total Debt
$170.0M
$170.0M
Dividend Yield
59.0%
59.0%
Trade Consideration
The Opportunity
Score 41.2 (P46 — top 53.5% of scored tickers). Weak Moat. Ethical PASS. 2 analysts at None.
Price: $108.46 | Target: $104.50 (+-4%) | Fair Value: $80.85 (+-25%)
Score
41
Moat
WEAK
Conviction
Standard
Upside
+-4%
The Fundamentals
Revenue Growth+3.6%
Profit Margin1.5%
ROE2.2%
Forward P/E20.1
Market Cap$599.2M
Earnings Track Record
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| 2026-05-27 | $1.39 | Pending | — |
| 2026-02-03 | $1.47 | $1.76 | +19.9% |
| 2025-11-06 | $1.56 | $2.11 | +35.1% |
| 2025-08-05 | $0.44 | $0.85 | +94.7% |
| 2025-05-28 | $2.07 | $0.43 | -79.4% |
| 2025-02-04 | $1.51 | $0.79 | -47.6% |
Position Sizing Scenarios
Stop: $92.19 (-15%) | Entry: $108.46
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($104.50, 2 analysts) | |||
| 10 | $1,084.60 | +$-39.60 (-4%) | -0.2R |
| 50 | $5,423.00 | +$-198.00 (-4%) | -0.2R |
| 100 | $10,846.00 | +$-396.00 (-4%) | -0.2R |
| To Fair Value ($80.85) | |||
| 10 | $1,084.60 | +$-276.10 (-25%) | -1.7R |
| 50 | $5,423.00 | +$-1,380.50 (-25%) | -1.7R |
| 100 | $10,846.00 | +$-2,761.00 (-25%) | -1.7R |
Risk Factors
- No elevated risk flags in current data
The Verdict
Mesa Laboratories, Inc. passes all ethical screens and holds a weak competitive moat.
Quantitative Grade
A single score combining all analytical layers below. A is strongest, D is weakest.
C
Quant Score
51.3
Risk Grade
—
Layers
8
Quality: STRONG_EARNINGS_DRIFT
Risk Profile
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
VaR 95%
-5.5%
worst expected daily loss, 19 in 20 days
CVaR 95%
-8.9%
avg loss on the worst 5% of days
Annual Volatility
—
Sortino Ratio
-0.06
above 1.0 is good
Max Drawdown
-62.8%
Worst Day
—
Forward Outlook
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
30d Prob Up
—
90d Prob Up
—
Median Return 30d
—
Liquidity Score
52
Liquidity Grade
MODERATE
Trend & Momentum
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Kalman Trend
—
Trend Strength
—
Momentum Signal
—
HMM Regime
—
RSI Signal
—
Technical Signals
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
MA Crossover
ABOVE_200
Bollinger Position
UPPER_HALF
Beta
—
Relative Volume
1.9x
Short Interest
—
Financial Health
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
Altman Z-Score
—
—
below 1.81 = distress zone
Piotroski F-Score
—
Earnings Beat Rate
62.5%
Earnings Consistency
—
Correlations
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
Most Correlated
| Ticker | Correlation |
|---|---|
| IWM | 0.499 |
| ARKG | 0.494 |
| ADJEX | 0.491 |
| TWST | 0.448 |
| A | 0.446 |
Inverse Correlated
| Ticker | Correlation |
|---|---|
| 4326.SR | -0.203 |
| CINECO.BH | -0.175 |
| 5099.KL | -0.145 |
| PKGS.KA | -0.142 |
| ITHMR.BH | -0.130 |
Seasonality
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
Best Day
Wednesday
Worst Day
Tuesday
Best Month
Feb
Worst Month
May
Fri-Mon Effect
-0.19352255451755726
Earnings Drift
After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.
Avg Drift After Beat
+8.4%
Beat Drift Positive %
100.0%
Consistency
—
Momentum Rankings
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.
1M Return
+8.4%
3M Return
+11.7%
6M Return
+48.8%
12M Return
-3.6%
Momentum Rank
#1045
Momentum Signal
UP